BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Topics
» HIV/AIDS, BioWorld Science
HIV/AIDS, BioWorld Science
RSS
HIV vaccine research at NIAID
Aug. 16, 1996
HIV integrase inhibitor effective, non-toxic in vitro
Aug. 16, 1996
Higher doses of GEM-91 administered in phase I/II trial
Aug. 16, 1996
Preclinical development of GEM-92 underway at Hybridon
Aug. 16, 1996
Bayer discloses HIV protease inhibitors
Aug. 16, 1996
VX-478 covered under U.S. patent for HIV/AIDS
Aug. 9, 1996
RD4-2025: Selective HIV-1 reverse transcriptase inhibitor in vitro
Aug. 9, 1996
GalaGen's Sporidin G enters phase II/III
Aug. 9, 1996
Immtech's r(m)CRP HIV treatment covered under U.S. patent
Aug. 9, 1996
Cel-Sci now holds full rights to HGP-30
Aug. 9, 1996
Previous
1
2
…
403
404
405
406
407
408
409
410
411
…
420
421
Next
RSS